ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,619.92
0.77%
US Tech 100
20,090.00
0.90%
Dow Jones
39,549.42
0.66%
Brent Oil
84.955
0.31%
Bitcoin
57,442.17
-0.99%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
02/22/202410:45AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
02/15/20246:34AMIH Market NewsCisco Systems Stock Drops 5% Following Restructuring Plan, Berkshire Trims Apple Stake, and Latest NewsNYSE:GSKGSK plc
02/08/20247:00AMGlobeNewswire Inc.Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s DiseaseNYSE:GSKGSK plc
02/07/20244:01PMGlobeNewswire Inc.23andMe Reports Third Quarter Fiscal 2024 Financial ResultsNYSE:GSKGSK plc
02/07/20247:00AMGlobeNewswire Inc.FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)NYSE:GSKGSK plc
02/06/20247:00AMBusiness WireGSK’s RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased RiskNYSE:GSKGSK plc
02/01/20246:51AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
01/31/20241:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
01/31/20246:28AMIH Market NewsWalmart’s Stock Split, Elon Musk’s Billion-Dollar Package Revoked, and MoreNYSE:GSKGSK plc
01/30/20244:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GSKGSK plc
01/29/20246:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
01/29/20246:26AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
01/24/20242:11PMBusiness WireElegen e GSK firmano un accordo di collaborazione e di licenza per sviluppare ulteriormente la tecnologia produttiva del DNA privo di cellule di ElegenNYSE:GSKGSK plc
01/24/202412:52PMBusiness WireElegen und GSK unterzeichnen Kooperations- und Lizenzvereinbarung zur Weiterentwicklung der zellfreien DNA-Produktionstechnologie von ElegenNYSE:GSKGSK plc
01/24/202411:37AMBusiness WireElegen et GSK signent un accord de collaboration et de licence pour continuer le développement de la technologie de production d’ADN acellulaire d’ElegenNYSE:GSKGSK plc
01/24/20248:00AMBusiness WireElegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production TechnologyNYSE:GSKGSK plc
01/19/20244:20PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:GSKGSK plc
01/19/202411:58AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
01/18/20247:49AMDow Jones NewsHilleVax Taps Sean McLoughlin as Chief Operating OfficerNYSE:GSKGSK plc
01/17/202412:46PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
01/17/202410:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
01/17/20248:45AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
01/17/20246:33AMIH Market NewsWall Street Highlights: Tesla Cuts Prices in Germany, Interactive Brokers Increases Revenue by 17%, and MoreNYSE:GSKGSK plc
01/17/20244:04AMDow Jones NewsCorrection to GSK Article on TuesdayNYSE:GSKGSK plc
01/17/20242:44AMDow Jones NewsGSK Sells Haleon Shares Valued Around $1.24 Billion Through Discounted PlacingNYSE:GSKGSK plc
01/16/20241:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
01/16/202412:19PMDow Jones NewsGSK to Sell Haleon Shares Worth Around $1.27 BillionNYSE:GSKGSK plc
01/10/20246:21AMIH Market NewsWall Street Highlights: Tesla Launches Restyled Model 3, VinFast Unveils Pickup Prototype, and MoreNYSE:GSKGSK plc
01/09/20246:37AMDow Jones NewsTrending: GSK Buys Asthma-Specialist Aiolos Bio For Up To $1.4 BillionNYSE:GSKGSK plc
01/09/20246:12AMIH Market NewsWall Street Highlights: HPE and Juniper Networks in Negotiations, Elliott Invests $1 Billion in Match Group, and MoreNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
MONI
Moon Equity (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
WDLF
Decentral Life (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
SFRX
Seafarer Exploration (PK)
NASDAQ
AMRN
Amarin
USOTC
CNNA
Cann American (CE)
USOTC
GDVM
Global Developments (PK)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
RDGL
Vivos (QB)
NASDAQ
MAXN
Maxeon Solar Technologies
USOTC
CLNV
Clean Vision (QB)
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved